GlassScriptPhysician profile
Vivek P Buch
NPI 1821352337
$58,127.64
in general payments reported to CMS, 2019-2025
9 companies · $20K in 2025
The $20K reported for 2025 was more than what 90% of Neurological Surgery providers received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $14.38 · 2020: $150 · 2021: $2,661 · 2022: $5,254 · 2023: $16K · 2024: $14K · 2025: $20K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $35K · Food and Beverage: $6,180 · Travel and Lodging: $4,930 · Consulting Fee: $4,338.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $34,600.00 |
| Food and Beverage | $6,179.99 |
| Travel and Lodging | $4,929.71 |
| Consulting Fee | $4,337.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $48,195.97 | 2020-2025 | Vercise, General - Dbs, General Dbs |
| Neuropace, INC. | $3,363.79 | 2022-2025 | |
| F. Hoffmann-La Roche Ag | $2,537.50 | 2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $1,421.70 | 2025 | |
| Clearpoint Neuro, INC. | $1,393.40 | 2023 | Clearpoint |
| Insightec,INC | $636.43 | 2022-2025 | Exablate |
| Medtronic, INC. | $564.47 | 2021-2025 | Percept PC Brainsense |
| Medtronic USA, INC. | $14.38 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vivek Buch listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.